- 英文名称
- Fmoc-ser(galnac(ac)3-alpha-d)-OH
- 分子式
- C32H36N2O13
- 分子量
- 656.63
- 中文别名
- Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH; N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-丝氨酸; N-芴甲氧羰基-O-(2-乙酰氨基-3,4,6-三-O-乙酰基-2-脱氧-Α-D-吡喃半乳糖基)-L-丝氨酸; N-芴甲氧羰基-O-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-丝氨酸; 半乳糖胺L-丝氨酸; FMOC-SER(AC3ACNH-Α-GAL)-OH; Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH; (2S)-3-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid; Fmoc-Ser(2-acetamido-3,4,6,-tri-O-acetyl-2-deoxy-alpha-D-galactopyranosyl)-OH; Fmoc-L-Tnser-OH; N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl]-L-serine; Fmoc-Ser-(Ac3AcNH-alpha-Gal)-OH; Fmoc-L-Ser(alpha-D-GalNAc(Ac)3)-OH; Fmoc-Ser(GalNAc(Ac)3-alpha-D)-OH; L-Serine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl]-; Fmoc-Ser(Ac3GalNAc-alpha)-OH; N-alpha-Fmoc-O-beta-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-serine; (2S)-3-({(2S,3R,4R,5R,6R)-3-Acetamido-4,5-bis(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl}oxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid; (2S)-3-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydropyran-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid; N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-((2S,3R,4R,5R,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)-L-serine; FMOC-SER(AC3ACNH-ALPHA-GAL)-OH; FMOC-SERINE(GALNAC(AC)3-ALPHA-D)-OH; FMOC-L-SER(TNAC4)-OH; GALNAC L-SERINE
- 用途
- 化学合成；作为抗肿瘤药物（Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH）的中间体或前体，用于相关药物的研发与制备。
